Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-66853366 |
| Mobile: | 13670046396 |
| E-mail: | orders@qcsrm.com |
| QQ: | 2851296956 |
| Skype: | Chat Now! |
| Address: | B1-203 & B3-402 Life Science Park SCT Creative Factory, Pingshan District ShenZhen, China |
| Product Name | MF | CAS | Details |
|---|
| Sitagliptin Impurity 79 | C16H15F6N5O | 486460-32-6 | Details |
| Sorafenib Tosylate Impurity F | C21H16ClF3N4O3 | 1431697-81-2 | Details |
| Simvastatin EP Impurity N(2-Methyl Simvastatin) | C26H40O5 | 774611-54-0 | Details |
| Sofosbuvir Impurity 32; Sofosbuvir Impurity B | C22H29ClN3O9P | 1496552-51-2 | Details |
| Saxagliptin Impurity 29 | C11H18N2O3 | 1564266-79-0 | Details |
| Safinamide Impurity C | C17H18FNO3 | 1160513-60-9 | Details |
| Solifenacin EP Impurity G | C23H26N2O2 | 740780-79-4 | Details |
| Sofosbuvir Impurity 16 | C16H13F5NO5P | 1911578-88-5 | Details |
| Sorafenib Tosylate Impurity K | C6H7NO2 | 3505-87-1 | Details |
| Sofosbuvir Impurity 95 | C10H13FN2O5 | 2041584-99-8 | Details |
| Sitagliptin Impurity 7 | C4H2ClF3N2O | 723286-98-4 | Details |
| Sitagliptin Phosphate Hydrate | C16H20F6N5O6P | 654671-77-9 | Details |
| Sunitinib Impurity 22 | C8H9NO3 | 253870-02-9 | Details |
| Sofosbuvir Impurity 59 | C10H14FN2O8P | 1015073-43-4 | Details |
| Saxagliptin (S,S,S,R)-Isomer | C18H25N3O2 | 1564265-93-5 | Details |
| Saxagliptin (S,R,S,R)-Isomer | C18H25N3O2 | 1564266-03-0 | Details |
| Spironolactone EP Impurity A | C24H30O4S | 132458-33-4 | Details |
| Sulpiride EP Impurity F | C15H23N3O5S | 2214214-03-4 | Details |
| Sorafenib Tosylate Impurity N | C17H19N3O4 | 2206827-14-5 | Details |
| Safinamide Impurity B | C17H19FN2O2 | 174756-44-6 | Details |
| Sunitinib N-Oxide | C22H27FN4O3 | 356068-99-0 | Details |
| Sitagliptin USP Phenylcrotonyl Analog | C16H12F6N4O | 1253056-18-6 | Details |
| Sulpiride EP Impurity G | C14H21N3O4S | 67381-52-6 | Details |
| Safinamide Impurity 2 | C21H16F2O2 | 1000370-24-0 | Details |
| Sofosbuvir Impurity 58 | C38H31N3O9 | 220503-64-0 | Details |
| Saxagliptin Impurity 19(Bms-554083) | C18H27N3O3 | 1496712-39-0 | Details |
| Sitagliptin Impurity 46 | C26H23F9N6O2 | 2072867-07-1 | Details |
| Sulpiride EP Impurity C | C10H13NO5S | 33045-53-3 | Details |
| Sorafenib Tosylate Impurity A | C13H13N3O2 | 284462-37-9 | Details |
| Simvastatin EP Impurity D | C50H76O10 | 476305-24-5 | Details |
| Sitagliptin Triazole Hydrochloride | C6H7F3N4.ClH | 762240-92-6 | Details |
| Sitagliptin Ketoamide Impurity | C16H12F6N4O2 | 764667-65-4 | Details |
| Sitagliptin Impurity 9 | C4H4ClF3N2O2 | 762240-99-3 | Details |
| Sitagliptin Acid | C10H10F3NO2 | 936630-57-8 | Details |
| Sugammadex Sodium Salt | C72H104Na8O48S8 | 343306-79-6 | Details |
| Sitagliptin Impurity 57 | C11H12F3NO2 | 881995-69-3 | Details |
| Sorafenib Tosylate Impurity D | C21H17F3N4O3 | 1285533-84-7 | Details |
| Sofosbuvir Impurity 22 | C16H18FN2O8P | 1859162-80-3 | Details |
| Sunitinib Impurity F | C8H6FNO | 56341-41-4 | Details |
| Simvastatin Impurity 39 | C23H34O5 | 79902-42-4 | Details |
| Silodosin Impurity 2 | C25H32F3N3O4 | 2182279-45-2 | Details |
| Sorafenib Tosylate Impurity E | C10H9ClF3NO2 | 18585-06-3 | Details |
| Sitagliptin Impurity H | C21H23F6N5O3 | 486460-23-5 | Details |
| Saxagliptin Impurity 8 | C18H25N3O | 361441-98-7 | Details |
| Saxagliptin (R,R,R,R)-Isomer | C18H25N3O2 | 1564265-95-7 | Details |
| Sitagliptin USP Styrylacetyl Analog | C16H12F6N4O | 1803026-58-5 | Details |
| Sofosbuvir Impurity 15 | C17H15F5NO5P | 1392015-05-2 | Details |
| Sunitinib Impurity 15 | C18H18FN3O2 | 1467015-10-6 | Details |
| Sitagliptin Impurity 44 | C8H11F3N6O | 1485732-85-1 | Details |
| Sorafenib Tosylate Impurity B | C16H17N3O4 | 2206827-12-3 | Details |
| Sofosbuvir Impurity 13 | C6H13NO2 | 39825-33-7 | Details |
| Simvastatin Impurity 45 | C25H40O7 | 159143-77-8 | Details |
| Simvastatin Impurity 38 | C26H40O5 | 864357-88-0 | Details |
| Silodosin Impurity 15 | C32H34F3N3O4 | 885340-11-4 | Details |
| Saxagliptin Impurity 27 | C11H18N2O3 | 1445592-86-8 | Details |
| Saxagliptin (R,S,R,R)-Isomer | C18H25N3O2 | 1564265-98-0 | Details |
| Sitafloxacin Impurity 51 | C10H14FNO3S | 185225-84-7 | Details |
| Sulpiride EP Impurity A ; Amisulpride EP Impurity A | C7H16N2 | 26116-12-1 | Details |
| Sorafenib Tosylate Impurity M | C14H13N3O3 | 2004659-84-9 | Details |
| Spironolactone EP Impurity H | C20H26O2 | 53866-24-3 | Details |
| Sitagliptin Fumarate Adduct (Mixture Of Diastereomers) | C20H19F6N5O5 | 2088771-60-0 | Details |
| Silybin A | C25H22O10 | 22888-70-6 | Details |
| Sorafenib Tosylate Impurity P | C7H7ClN2O | 220000-87-3 | Details |
| Saxagliptin | C18H25N3O2 | 361442-04-8 | Details |
| Simvastatin EP Impurity F; Lovastatin Epi-Isomer | C24H36O5 | 79952-44-6 | Details |
| Sofosbuvir Nucleoside Derivative | C10H13FN2O5 | 863329-66-2 | Details |
| Saxagliptin Dihydroxy Impurity(5-Hydroxy Saxagliptin) | C18H25N3O3 | 841302-24-7 | Details |
| Sofosbuvir Impurity 96 | C24H21FN2O7 | 863329-65-1 | Details |
| Spironolactone EP Impurity E | C24H32O4S | 33784-05-3 | Details |
| Saxagliptin Impurity 4 | C17H27NO5 | 1334321-39-9 | Details |
| Sitagliptin Impurity A | C6H5F3N4O | 877402-45-4 | Details |
| Sorafenib Tosylate Impurity Y | C27H23N5O6 | 2204442-52-2 | Details |
| Salicylic Acid Impurity 46 | C7H5NO4 | 1172605-63-8 | Details |
| Sodium Calcium Edetate | C10H12CaN2Na2O8.xH2O | 62-33-9 | Details |
| Safinamide | C17H19FN2O2 | 133865-89-1 | Details |
| D-Sorbitol; Xylitol EP Impurity D | C6H14O6 | 50-70-4 | Details |
| Simvastatin EP Impurity G | C25H36O5 | 1449248-72-9 | Details |
| Sitagliptin N-Acetyl Impurity | C18H17F6N5O2 | 1379666-94-0 | Details |
| Saxagliptin Impurity 9(Bms-700047) | C18H24N2O3 | 1350800-77-9 | Details |
| Saxagliptin (R,S,R,S)-Isomer | C18H25N3O2 | 1564265-96-8 | Details |
| Sofosbuvir Impurity 82 | C16H25FN3O9P | 1233335-82-4 | Details |
| Safinamide Impurity 1 | C24H24F2N2O2 | 1000370-27-3 | Details |
| Sorafenib Tosylate Impurity O | C27H24N6O5 | 284670-98-0 | Details |
| Sulpiride EP Impurity D | C8H9NO5S | 22117-85-7 | Details |
| Safinamide Impurity V | C17H19FN2O2 | 202825-43-2 | Details |
| Sorafenib Tosylate Impurity T | C20H19N5O3 | 2004659-83-8 | Details |
| Sunitinib Impurity A | C22H27FN4O2 | 1691223-83-2 | Details |
| Sulpiride EP Impurity E | C8H10N2O4S | 52395-25-2 | Details |
| Sitafloxacin Impurity 43 | C13H8F3NO3 | 127199-00-2 | Details |
| Saxagliptin Impurity 17(Bms-537679) | C18H25N3O2 | 1350800-76-8 | Details |
| Saxagliptin Impurity 23 | C17H27NO6 | 681282-72-4 | Details |
| Saxagliptin (R,R,R,S)-Isomer | C18H25N3O2 | 1564265-94-6 | Details |
| Saxagliptin (S,R,S,S)-Isomer | C18H25N3O2 | 1564266-00-7 | Details |
| Simvastatin EP Impurity B | C27H40O6 | 145576-25-6 | Details |
| Sunitinib Impurity 34 | C16H13FN2O3 | 356068-93-4 | Details |
| Simvastatin EP Impurity C | C25H36O4 | 210980-68-0 | Details |
| Sitagliptin Impurity 68(Mixture Of Z And E Isomers) | C16H12F6N4O | 1675201-14-5 | Details |
| Sulpiride EP Impurity B | C9H11NO5S | 33045-52-2 | Details |
| Simvastatin | C25H38O5 | 79902-63-9 | Details |
| Sodium Citrate Dihydrate | C6H9Na3O9 | 6132-04-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 | ||||